Literature DB >> 2822970

Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein.

R Ostermayr1, K von der Helm, V Gauss-Müller, E L Winnacker, F Deinhardt.   

Abstract

The genome of hepatitis A virus (HAV) was reverse transcribed into cDNA and molecularly cloned. cDNA clones coding for the capsid protein VP1 that carries the major HAV antigen were cloned into the expression vector pUR290 and expressed in Escherichia coli. The recombinant fusion protein reacted in an immunoblot with rabbit anti-HAV serum, suggesting that it possesses HAV antigenicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822970      PMCID: PMC255970          DOI: 10.1128/JVI.61.11.3645-3647.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Propagation of human hepatitis A virus in cell culture in vitro.

Authors:  P J Provost; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

3.  Propagation of hepatitis A virus in human embryo fibroblasts.

Authors:  V Gauss-Müller; G G Frösner; F Deinhardt
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

4.  Evidence that the genome of hepatitis A virus consists of single-stranded RNA.

Authors:  A G Coulepis; G A Tannock; S A Locarnini; I D Gust
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

5.  Classification of hepatitis A virus as enterovirus type 72 and of hepatitis B virus as hepadnavirus type 1.

Authors:  J L Melnick
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

6.  Propagation of human hepatitis A virus in a hepatoma cell line.

Authors:  G G Frösner; F Deinhardt; R Scheid; V Gauss-Müller; N Holmes; V Messelberger; G Siegl; J J Alexander
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Molecular cloning and characterization of hepatitis A virus cDNA.

Authors:  J R Ticehurst; V R Racaniello; B M Baroudy; D Baltimore; R H Purcell; S M Feinstone
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Cloning of hepatitis A virus genome.

Authors:  K von der Helm; E L Winnacker; F Deinhardt; G Frösner; V Gauss-Müller; B Bayerl; R Scheid; G Siegl
Journal:  J Virol Methods       Date:  1981-07       Impact factor: 2.014

10.  Restricted replication of human hepatitis A virus in cell culture: intracellular biochemical studies.

Authors:  S A Locarnini; A G Coulepis; E G Westaway; I D Gust
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  6 in total

Review 1.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice.

Authors:  Ho Yong Chung; Hyun Ho Lee; Kyung Il Kim; Ha Young Chung; Jeon Hwang-Bo; Jong Hwa Park; Garry Sunter; Jong Bum Kim; Dong Hwa Shon; Wonyong Kim; In Sik Chung
Journal:  Plant Cell Rep       Date:  2011-03-27       Impact factor: 4.570

3.  Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.

Authors:  L H Ping; R W Jansen; J T Stapleton; J I Cohen; S M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 4.  Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.

Authors:  B J Kendall; W G Cooksley
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

5.  Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.

Authors:  F D LaBrecque; D R LaBrecque; D Klinzman; S Perlman; J B Cederna; P L Winokur; J Q Han; J T Stapleton
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

6.  Solubility as a limiting factor for expression of hepatitis A virus proteins in insect cell-baculovirus system.

Authors:  Haroldo Cid da Silva; Cristiane Pinheiro Pestana; Ricardo Galler; Marco Alberto Medeiros
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-07-11       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.